An evaluation of patients with a previous endemic coronavirus infection during the COVID-19 pandemic

Basit Öğe Kaydı
dc.authoridTanriverdi, Elif Seren/0000-0002-0449-0356
dc.authoridYAKUPOGULLARI, YUSUF/0000-0002-5545-3467
dc.authoridBAYINDIR, Yasar/0000-0003-3930-774X
dc.authoridOtlu, Baris/0000-0002-6220-0521
dc.authorwosidTanriverdi, Elif Seren/ABE-4472-2021
dc.authorwosidYAKUPOGULLARI, YUSUF/F-3966-2011
dc.contributor.authorOtlu, Baris
dc.contributor.authorYakupogullari, Yusuf
dc.contributor.authorTanriverdi, Elif S.
dc.contributor.authorBayindir, Yasar
dc.date.accessioned2024-08-04T20:49:25Z
dc.date.available2024-08-04T20:49:25Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractFew studies exist on the clinical manifestation of coronavirus disease 2019 (COVID-19) in patients who previously had a common cold due to an endemic coronavirus (eCoV). In a retrospective scan of the data obtained in our microbiology laboratory, 64 patients who were diagnosed with an eCoV infection between 2016 and 2020 were identified. National COVID-19 surveillance data showed that four (6.2%) of 64 patients were infected with severe acute respiratory syndrome coronavirus 2 by the end of 2020, while, simultaneously, the COVID-19 prevalence in the city of Malatya ranged from 7.8% (polymerase chain reaction-based diagnosis) to 9.2% (total diagnosis). The differences were found statistically significant (6.2% vs. 7.8%, p < .01; 6.2% vs. 9.2%, p < .001). Patient interviews and evaluation of medical records revealed that these four patients did not manifest any severe COVID-19 symptoms despite their substantial comorbidities, and they did not require hospitalization. Consequently, despite a low number of samples, we determined a lower frequency of COVID-19 among the patients who had a prior eCoV infection, and the results of this study support the previous findings that people with a prior eCoV infection develop a milder case of COVID-19. Our results may provide some insights for future studies aiming at vaccine development, but detailed investigations are still required.en_US
dc.identifier.doi10.1002/jmv.26942
dc.identifier.endpage4548en_US
dc.identifier.issn0146-6615
dc.identifier.issn1096-9071
dc.identifier.issue7en_US
dc.identifier.pmid33724483en_US
dc.identifier.scopus2-s2.0-85103149493en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage4544en_US
dc.identifier.urihttps://doi.org/10.1002/jmv.26942
dc.identifier.urihttps://hdl.handle.net/11616/99852
dc.identifier.volume93en_US
dc.identifier.wosWOS:000632523800001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofJournal of Medical Virologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcoronavirusen_US
dc.subjectpandemicsen_US
dc.subjectrespiratory tracten_US
dc.subjectSARS coronavirusen_US
dc.titleAn evaluation of patients with a previous endemic coronavirus infection during the COVID-19 pandemicen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu